JasonJSuhMD

Oncology • Lacey, WA

Hematology/Oncology consultant at Duly Clinic

Join to view full profile

Dr. Suh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Suh's full profile

Already have an account?

Office
700 Lilly Rd NE
Lacey, WA 98506
Phone+1 360-923-7000
Is this information wrong?

Summary

Dr. Jason Suh is an oncologist in Joliet, IL and is affiliated with multiple hospitals in the area, including Morris Hospital & Healthcare Centers, AMITA Health Mercy Medical Center, AMITA Health Saint Joseph Hospital, Silver Cross Hospital, and AMITA Health Saint Joseph Medical Center. He received his medical degree from Kyungpook National University College of Medicine and has been in practice 28 years. He has 8 publications.

Education & Training

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1997 - 1998
Kyungpook National University College of MedicineClass of 1989
Wyckoff Heights Medical CenterResidency, Internal Medicine

Certifications & Licensure

NV State Medical License 2024 - 2025
WA State Medical License 2022 - 2025
AZ State Medical License 2022 - 2024
IL State Medical License 2002 - 2023
NC State Medical License 2000 - 2002
PA State Medical License 1998 - 2000
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC Start of enrollment: 2016 Nov 30
Completed
Phase 3
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Start of enrollment: 2017 Jun 07
Terminated
Phase 3

Publications & Presentations

PubMed

RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendr...
Vogelbaum MA, Berkey B, Peereboom D, Giannini C, Jenkins R, Suh J, Brown P, Blumenthal D, Biggs C, Mehta M> ;J. Clin. Oncol.. 2006-06-20
RTOG 0131: Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligodendr...
Vogelbaum MA, Berkey B, Peereboom D, Giannini C, Suh J, Brown P, Blumenthal D, Biggs C, Schultz C, Mehta M> ;J. Clin. Oncol.. 2005-06-01
Does the sequence of stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) affect treatment related morbidity in melanoma patients with brain metast...
Kaur H, Suh J, Vogelbaum M, Barnett GH, Elson P, Olencki TE> ;J. Clin. Oncol.. 2004-07-15
Pharmacokinetics (PK) of RSR13 (efaproxiral) predict survival in patients with brain metastases randomized to receive whole brain radiation therapy (WBRT) with or with...
Shaw E, Stea B, Pinter T, Hammoud Y, Cagnoni PJ, Hackman J, Boyd A, Craig M, Marks J, Suh J> ;J. Clin. Oncol.. 2004-07-15
Standard whole brain radiation therapy (WBRT) with supplemental oxygen (O2), with or without RSR13 (efaproxiral)in patients with brain metastases: Results of the rando...
Suh J, Stea B, Nabid A, Kresl J, Fortin A, Mercier JP, Senzer N, Chang E, Holz JB, Shaw E> ;J. Clin. Oncol.. 2004-07-15
Safety profile of efaproxiral (RSR13), a novel radiation sensitizer, in patients undergoing radiation therapy.
Stea B, Nabid A, Kresl J, Roa W, Mechtler L, Senzer N, Germain I, Kass CL, Shaw E, Suh J> ;J. Clin. Oncol.. 2004-07-15
Standard whole brain radiation (WBRT) with supplemental oxygen (O2) with or without RSR13 (efaproxiral) in patients with brain metastases originating from NSCLC: Resul...
Nabid A, Kresl J, Stea B, Mercier JP, Roa W, Germain I, Bahary J, Mechtler L, Holz JB, Suh J> ;J. Clin. Oncol.. 2004-07-15
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05...
Moraska, A. R., Sood, A., Dakhil, S. R., Sloan, J. A., Barton, D., Atherton, P. J., Suh, J. J., Griffin, P. C., Johnson, D. B., Ali, A., Silberstein, P. T., Duane, S. ...> ;J Clin Oncol. 2010 Aug 10
Join now to see all

Hospital Affiliations

Morris Hospital & Healthcare CentersMorris, Illinois
AMITA Health Mercy Medical CenterAurora, Illinois
AMITA Health Saint Joseph HospitalChicago, Illinois
Silver Cross HospitalNew Lenox, Illinois
AMITA Health Saint Joseph Medical CenterJoliet, Illinois